YAP/TAZ: Molecular pathway and disease therapy
MedComm · 2023-08 · 4 (4)
DOI: 10.1002/mco2.340 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 09.08.2023. Verfasst von Yuzi Wei und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology Sichuan University Ch…. Die Arbeit wurde bisher 100-mal zitiert (Crossref) und nennt 418 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The Yes‐associated protein and its transcriptional coactivator with PDZ‐binding motif (YAP/TAZ) are two homologous transcriptional coactivators that lie at the center of a key regulatory network of Hippo, Wnt, GPCR, estrogen, mechanical, and metabolism signaling. YAP/TAZ influences the expressions of downstream genes and proteins as well as enzyme activity in metabolic cycles, cell proliferation, inflammatory factor expression, and the transdifferentiation of fibroblasts into myofibroblasts. YAP/TAZ can also be regulated through epigenetic regulation and posttranslational modifications. Consequently, the regulatory function of these mechanisms implicates YAP/TAZ in the pathogenesis of metabolism‐related diseases, atherosclerosis, fibrosis, and the delicate equilibrium between cancer progression and organ regeneration. As such, there arises a pressing need for thorough investigation of YAP/TAZ in clinical settings. In this paper, we aim to elucidate the signaling pathways that regulate YAP/TAZ and explore the mechanisms of YAP/TAZ‐induce diseases and their potential therapeutic interventions. Furthermore, we summarize the current clinical studies investigating treatments targeting YAP/TAZ. We also address the limitations of existing research on YAP/TAZ and propose future directions for research. In conclusion, this review aims to provide fresh insights into the signaling mediated by YAP/TAZ and identify potential therapeutic targets to present innovative solutions to overcome the challenges associated with YAP/TAZ.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology Sichuan University Chengdu Sichuan China.
- Department of Orthodontics West China Hospital of Stomatology Sichuan University Chengdu Sichuan China.
- Department of Orthodontics Lanzhou Stomatological Hospital Lanzhou Gansu China.
ORCID-Profile: Yongwen Guo
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wei, Y., Hui, V. L. Z., Chen, Y., Han, R., Han, X., & Guo, Y. (2023). YAP/TAZ: Molecular pathway and disease therapy. MedComm, 4(4). https://doi.org/10.1002/mco2.340
Vancouver
Wei Y, Hui VLZ, Chen Y, Han R, Han X, Guo Y. YAP/TAZ: Molecular pathway and disease therapy. MedComm. 2023;4(4). doi:10.1002/mco2.340
BibTeX
@article{Wei2023,
author = {Wei, Yuzi and Hui, Victoria Lee Zhi and Chen, Yilin and Han, Ruiying and Han, Xianglong and Guo, Yongwen},
title = {YAP/TAZ: Molecular pathway and disease therapy},
journal = {MedComm},
year = {2023},
volume = {4},
number = {4},
doi = {10.1002/mco2.340}
}
EUVIMED